Showing results (231-240 of 276) with videos related to

Sort By:
Pageof 28
Blood|April 22, 2020
A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemiaAmir Enshaei, David O'Connor, Jack Bartram, et al.
Leukemia|October 4, 2017
RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemiaI S Jerchel, A Q Hoogkamer, I M Ariës, et al.
The Lancet. Haematology|September 24, 2021
Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort studyNaomi Michels, Judith M Boer, Amir Enshaei, et al.
Haematologica|September 26, 2015
Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemiaMarissa A H den Hoed, Saskia M F Pluijm, Mariël L te Winkel, et al.
Ebiomedicine|November 11, 2023
Mycoplasma pneumoniae carriage in children with recurrent respiratory tract infections is associated with a less diverse and altered microbiotaMischa H Koenen, Ruben C A de Groot, Wouter A A de Steenhuijsen Piters, et al.
Molecular Cancer Therapeutics|May 8, 2026
Tri-specific Humabody CB307 Targeting CD137, Prostate-specific Membrane Antigen, and Human Serum Albumin Whole-body Biodistribution Measured with 89Zr-CB307 PETDaan G Knapen, Claudia Aj van Winkel, Tom Grevelink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2019
<sup>89</sup>Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor UptakeKirsten L Moek, Stijn J H Waaijer, Iris C Kok, et al.
Virchows Archiv : an International Journal of Pathology|October 18, 2023
Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomasLorraine M de Haan, Ruben A L de Groen, Fleur A de Groot, et al.
The Lancet. Haematology|December 28, 2020
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort studyMonique L den Boer, Gunnar Cario, Anthony V Moorman, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemiaJoost B Koedijk, Inge van der Werf, Livius Penter, et al.
Pageof 28